Pfizer recently announced it would increase the U.S. list price of its patented Covid treatment nirmatrelvir-ritonavir to $1,390 for a five-day treatment course.
Experts at Harvard University have estimated that the cost of producing a five-day course of nirmatrelvir-ritonavir is $13. Public Citizen published an analysis this week finding that more than eight million people with high-risk Covid infections in low- and middle-income countries in 2022 could not access Paxlovid, leaving more than 90% of health need unmet. Peter Maybarduk, director of the Access to Medicines program at Public Citizen released the following statement.
“Pfizer has made tens of billions in Paxlovid sales, largely through major government purchases. Pfizer could choose now to support the fight against Covid and ease treatment access by lowering its already inflated prices.“Instead, Pfizer chose to double its U.S. price just as pandemic funding falters and the precarious winter viral season begins. This will strain health budgets and contribute to further treatment rationing.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day CourseDrugmaker is expected to offer steep discounts to ensure wide access
Lire la suite »
Pfizer to price COVID treatment Paxlovid at $1,390 per coursePfizer on Wednesday (PFE.N) said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out.
Lire la suite »
Pfizer to price Covid drug Paxlovid at $1,390 per coursePaxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Lire la suite »
Pfizer to price Covid drug Paxlovid at $1,390 per coursePaxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Lire la suite »
Pfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial MarketNick Visser is a senior reporter on HuffPost’s breaking news team, covering the environment, U.S. politics and world news. Originally based in New York, he now lives in Sydney.
Lire la suite »
Pfizer more than doubles price of lifesaving COVID-19 medication PaxlovidThe price of the lifesaving COVID-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic.
Lire la suite »